However, in IR these indirect pathways are not blocked, in part because insulin is unable to adequately regulate the gene expression and function of PEPCK [97] and G6Pase [98], leading to excessive hepatic glucose production through gluconeogenesis and glycogenolysis, thereby contributing to fasting hyperglycemia [50,51,52]. This evidence concerns the gene G6PC1 and Hyperglycemia.